Softwr

Healthcare · head to head

Lunit vs Nookal

Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-
Full reviewWebsite
Nookal logo

Nookal

Healthcare

Australian allied health practice management priced per practitioner with usage charges on top

From
49/month
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.; Nookal the features most multi-practitioner clinics need, including advanced reporting, custom forms and automated recalls, are held back to the Professional tier, so the AUD 49 entry price is not a realistic budget for anything beyond a solo practice.
  • They diverge on capability: Lunit covers Lunit INSIGHT MMG, Nookal covers Per practitioner pricing.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Lunit and Nookal actually diverge.

Attributes where Lunit and Nookal differ
AttributeLunitNookal
Starting priceOn request49/month
Pricing modelquotePer user per month
PlatformsWebWeb, iOS, Android

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

Only in Nookal

  • Per practitioner pricing
  • Clinical notes
  • Online booking
  • Automated recalls
  • KPI dashboards
  • Claiming
  • Patient portal
  • AI and voice

What people use each for

The jobs each tool is most often brought in to do.

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Nookal
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Nookal
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Nookal
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Nookal

Nookal

  • A three to ten practitioner physiotherapy clinic in Australia that wants Medicare claiming and published pricing rather than a quote processnot Lunit
  • A New Zealand practice that needs ACC claim submission integrated with its clinical notes and billingnot Lunit
  • A chiropractic group opening a second location that wants shared patient records and one reporting view across sitesnot Lunit
  • A UK or Irish allied health clinic that wants an Australian-style clinical workflow with GBP or EUR billingnot Lunit

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Nookal

  • The features most multi-practitioner clinics need, including advanced reporting, custom forms and automated recalls, are held back to the Professional tier, so the AUD 49 entry price is not a realistic budget for anything beyond a solo practice.
  • Add-ons stack quickly: AI and voice at about USD 25 per active licence, the patient portal from USD 10 per location and secure messaging from USD 1.50 per user can push a seat close to double its list price.
  • Pricing is not a simple currency conversion, with the USD Essentials tier at 65 and Professional at 89 against AUD 49 and 59, so overseas clinics pay a meaningful premium for the same software.
  • Messaging and claiming are metered per SMS and per claim, so a clinic that leans on reminders to control no-shows finds a variable line item that grows with appointment volume and is easy to underestimate at purchase.
  • Single sign-on is quoted rather than listed and sits with the Enterprise tier, which puts basic identity governance out of reach for mid-sized groups that would otherwise stay on Professional.

Pricing, plan by plan

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Nookal

49/month
  • Essentials$49/month
    • Per practitioner per month
    • Appointments, patient records and invoicing
    • Online booking
  • Professional$59/month
    • Per practitioner per month
    • Advanced reporting and KPI dashboards
    • Custom forms
  • Enterprise$undefined/month
    • Quoted pricing
    • Multi-account management
    • Dedicated support

Which should you pick?

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.
Lunit review

Choose Nookal if

  • You need per practitioner pricing.
  • You work on Web, iOS, Android.
  • You also want clinical notes.
Nookal review

Questions people ask

Is Lunit or Nookal better?
Neither clearly leads. Lunit starts at On request and Nookal at 49/month, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Lunit or Nookal?
Lunit starts at On request and Nookal at 49/month.
Does Lunit or Nookal run on more platforms?
Lunit runs on Web. Nookal runs on Web, iOS, Android.
What is Lunit best used for?
Lunit is most often used for a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated, a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically, an american breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what volpara is bought for, a tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise films. Of those, a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated and a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically are not what Nookal is typically brought in for.
What can Lunit do that Nookal cannot?
Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment. Nookal covers Per practitioner pricing, Clinical notes, Online booking, Automated recalls.

Answered from the vendors’ own pages

Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Nookal: How much does Nookal cost per practitioner?

Essentials is AUD 49 per practitioner per month and Professional is AUD 59, with published equivalents of GBP 29 and 39, EUR 65 and 89, and USD 65 and 89. Enterprise is quoted.

Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Nookal: What is not included in the subscription?

SMS from about 7 cents per message, Medicare claims from about 10 cents, ACC claims at about 12 cents, the patient portal, secure messaging, AI and voice, and single sign-on are all charged separately.

Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Nookal: Is there a contract?

No lock-in contract, and the free trial does not require a credit card.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Nookal: Which countries does the claiming work in?

Medicare claiming is Australian and ACC claiming is New Zealand. Elsewhere the software works but you invoice and reconcile manually.

Share

Related pages

More on Lunit

More on Nookal

Keep looking

Other head to heads